SynthesisBMC infectious diseases2025
Containment and response strategies for mpox outbreaks: a systematic review.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Factors influencing selection of models of primary health care delivery in conflict-affected settings: analysis of surveys from humanitarian organizations in Cameroon and Nigeria.BMC health services research · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMpox, primarily endemic to Central and West Africa, has seen a concerning global rise in recent years. There is a critical need to synthesize evidence on successful strategies that have been used to contain and respond to mpox globally to inform policy and best practices.
methodsA systematic review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Four databases were searched for publications between 2017 to August 2024. Articles were included if they reported on mpox response and containment strategies.
resultsA total of 72 studies were included in this systematic review. During mpox outbreaks, screening was primarily conducted at sexual health clinics, including Sexually Transmitted Infections and PrEP (Pre-exposure prophylaxis) clinics. PCR (Polymerase chain reaction) testing was the most commonly reported diagnostic method. Three treatment options were identified: Tecovirimat, Vaccinia Immune Globulin, and Cidofovir. Additionally, vaccines were classified into two main categories: (i) JYNNEOS (also known as MVA-BN and IMVANEX) and (ii) ACAM2000. Studies highlighted several challenges associated with isolation measures, including difficulties in maintaining consistent follow-up, ensuring patient compliance, and managing large-scale isolation logistics. Surveillance strategies emphasized effective data collection, case investigations, and public health coordination to strengthen outbreak response. Pre-emergency preparedness efforts focused on international collaboration, the development of distribution networks, models of care for Mpox treatment, and the analysis of past outbreaks to improve future response strategies.
conclusionThis review synthesized strategies for mpox outbreak response and containment, highlighting the need to expand vaccine access beyond GBMSM/LGBTQIA + populations, integrate screening into routine sexual health services, adopt alternative delivery and diagnostic approaches, strengthen surveillance and pre-emergency preparedness, and promote context-specific research in low- and middle-income countries to inform evidence-based policy and practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.